Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
bioSyntagma
bioSyntagma gives clinicians and researchers a patient-specific view of cancer to inform therapy selection and limit acquired drug resistance. The company’s mPrint molecular fingerprint platform…
bioSyntagma
bioSyntagma gives clinicians and researchers a patient-specific view of cancer to inform therapy selection and limit acquired drug resistance. The company’s mPrint molecular fingerprint platform…
TL;DR
Founded: 2015
Headquarters: Phoenix, Arizona, United States
Product: mPrint multi-omic, spatial molecular fingerprinting platform for precision oncology
Funding: Multiple grants; last recorded grant Mar 19, 2018; total reported funding $1,382,086 USD
Company Overview
Problem Domain
Precision oncology — diagnostic and therapeutic decision support using multi-omic and spatial molecular profiling
Founded
2015
Industry
Biotechnology
Funding Track Record
Most recent recorded grant dated Mar 19, 2018
Investor Signal
“National Science Foundation; National Institutes of Health”
Founders
What we do
Join the Team
Startup jobs. A lot of them.
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
60,000+
Open Roles
200+
New This Week